全科实践中肩痛皮质类固醇注射的使用与安全性:回顾性队列研究
该回顾性队列研究利用约20万患者全科电子病历数据库,识别2012年1月至2017年12月新发肩痛患者,并对两个各1000例随机样本诊断后12个月内皮质类固醇注射使用进行人工验证,发现26%患者接受注射,半数在首次就诊时即注射,年龄和肩痛史与注射显著相关,全科医生未记录严重不良反应。
要点
- 26%新发肩痛患者接受皮质类固醇注射,半数在首次就诊时即注射。
- 年龄较大和有肩痛史者更可能接受皮质类固醇注射。
- 全科医生未记录到严重不良反应。
核心结论
- 与指南推荐不同,皮质类固醇注射常在首次就诊时即用于新发肩痛患者。
- 年龄较大和有肩痛史的患者更可能接受皮质类固醇注射。
- 全科医生未记录到严重不良反应。
研究设计与样本
- 回顾性队列研究,使用包含约20万全科患者电子病历的医疗数据库。
- 构建搜索算法识别2012年1月至2017年12月新发肩痛患者。
- 对两个随机样本(各n=1000)诊断后12个月内皮质类固醇注射使用进行人工验证。
主要发现
- 26%的新发肩痛患者接受了皮质类固醇注射。
- 患者年龄(OR 1.03,95% CI 1.02-1.04)和肩痛史(OR 1.52,95% CI 1.13-2.12)与接受注射显著相关。
- 半数患者首次就诊即接受皮质类固醇注射。
- 年龄与首次就诊即接受注射的可能性正相关(OR 1.01,95% CI 1.00-1.02)。
- 全科医生未记录严重不良反应。
关键数值与推荐
- 新发肩痛患者接受皮质类固醇注射的比例为26%。
- 年龄与注射相关的OR为1.03(95% CI 1.02-1.04)。
- 肩痛史与注射相关的OR为1.52(95% CI 1.13-2.12)。
- 年龄与首次就诊即注射相关的OR为1.01(95% CI 1.00-1.02)。
临床怎么用
- 全科医生应关注新发肩痛患者首次就诊即注射皮质类固醇的实践与指南推荐不一致。
- 对年龄较大和有肩痛史的患者,应结合指南评估注射的必要性。
- 尽管未记录严重不良反应,仍需关注皮质类固醇注射的安全性。
局限性
- 回顾性研究设计可能受数据记录完整性影响。
- 使用人工验证的两个随机样本,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines for shoulder pain in general practice recommend treatment with corticosteroid injections (CSI) if initial pain management fails. However, little is known about the actual use and safety of CSIs in treatment by general practitioners (GP). OBJECTIVE: The objective of this study was to gain insight into the use and safety of CSIs for patients with a new episode of shoulder pain in general practice. METHODS: A retrospective cohort study was conducted using a healthcare database containing the electronic medical records of approximately 200,000 patients in general practice. A search algorithm was constructed to identify patients with a new episode of shoulder pain between January 2012 and December 2017. Data on the use of CSIs in 2 random samples (n = 1,000) were manually validated for a 12-month period after the diagnosis. RESULTS: In total, 26% of the patients with a new episode of shoulder pain received a CSI. The patient's age (OR 1.03, 95% CI 1.02-1.04) and a history of shoulder pain (OR 1.52, 95% CI 1.13-2.12) were significantly associated with the administration of a CSI. Half of the patients received the CSI in the first consultation. The patient's age was positively associated with the likelihood of receiving the CSI in the first consultation (OR 1.01, 95% CI 1.00-1.02). No serious adverse reactions were recorded by the GP. CONCLUSION: In contrast to the guidelines, CSIs were frequently administered in the first consultation. Older patients and patients with a history of shoulder pain were more likely to receive a CSI for shoulder pain.
引用
- van Doorn PF, Schiphof D, Rozendaal RM, et al. The use and safety of corticosteroid injections for shoulder pain in general practice: a retrospective cohort study. Fam Pract. 2022. PMID: 34623417. doi:10.1093/fampra/cmab116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。